Cargando…
Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST)
BACKGROUND: Studies on time to diagnosis are an increasing field of clinical research that may help to plan corrective actions and identify inequities in access to healthcare. Specific features of time to diagnosis studies, such as how participants were selected and how time to diagnosis was defined...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039933/ https://www.ncbi.nlm.nih.gov/pubmed/27677259 http://dx.doi.org/10.1186/s12916-016-0690-7 |
_version_ | 1782456152095719424 |
---|---|
author | Launay, Elise Cohen, Jérémie F. Bossuyt, Patrick M. Buekens, Pierre Deeks, Jonathan Dye, Timothy Feltbower, Richard Ferrari, Andrea Kramer, Michael Leeflang, Mariska Moher, David Moons, Karel G. von Elm, Erik Ravaud, Philippe Chalumeau, Martin |
author_facet | Launay, Elise Cohen, Jérémie F. Bossuyt, Patrick M. Buekens, Pierre Deeks, Jonathan Dye, Timothy Feltbower, Richard Ferrari, Andrea Kramer, Michael Leeflang, Mariska Moher, David Moons, Karel G. von Elm, Erik Ravaud, Philippe Chalumeau, Martin |
author_sort | Launay, Elise |
collection | PubMed |
description | BACKGROUND: Studies on time to diagnosis are an increasing field of clinical research that may help to plan corrective actions and identify inequities in access to healthcare. Specific features of time to diagnosis studies, such as how participants were selected and how time to diagnosis was defined and measured, are poorly reported. The present study aims to derive a reporting guideline for studies on time to diagnosis. METHODS: Each item of a list previously used to evaluate the completeness of reporting of studies on time to diagnosis was independently evaluated by a core panel of international experts (n = 11) for relevance and readability before an open electronic discussion allowed consensus to be reached on a refined list. The list was then submitted with an explanatory document to first, last and/or corresponding authors (n = 98) of published systematic reviews on time to diagnosis (n = 45) for relevance and readability, and finally approved by the core expert panel. RESULTS: The refined reporting guideline consists of a 19-item checklist: six items are about the process of participant selection (with a suggested flowchart), six about the definition and measurement of time to diagnosis, and three about optional analyses of associations between time to diagnosis and participant characteristics and health outcomes. Of 24 responding authors of systematic reviews, more than 21 (≥88 %) rated the items as relevant, and more than 17 (≥70 %) as readable; 19 of 22 (86 %) authors stated that they would potentially use the reporting guideline in the future. CONCLUSIONS: We propose a reporting guideline (REST) that could help authors, reviewers, and editors of time to diagnosis study reports to improve the completeness and the accuracy of their reporting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0690-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5039933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50399332016-10-05 Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST) Launay, Elise Cohen, Jérémie F. Bossuyt, Patrick M. Buekens, Pierre Deeks, Jonathan Dye, Timothy Feltbower, Richard Ferrari, Andrea Kramer, Michael Leeflang, Mariska Moher, David Moons, Karel G. von Elm, Erik Ravaud, Philippe Chalumeau, Martin BMC Med Guideline BACKGROUND: Studies on time to diagnosis are an increasing field of clinical research that may help to plan corrective actions and identify inequities in access to healthcare. Specific features of time to diagnosis studies, such as how participants were selected and how time to diagnosis was defined and measured, are poorly reported. The present study aims to derive a reporting guideline for studies on time to diagnosis. METHODS: Each item of a list previously used to evaluate the completeness of reporting of studies on time to diagnosis was independently evaluated by a core panel of international experts (n = 11) for relevance and readability before an open electronic discussion allowed consensus to be reached on a refined list. The list was then submitted with an explanatory document to first, last and/or corresponding authors (n = 98) of published systematic reviews on time to diagnosis (n = 45) for relevance and readability, and finally approved by the core expert panel. RESULTS: The refined reporting guideline consists of a 19-item checklist: six items are about the process of participant selection (with a suggested flowchart), six about the definition and measurement of time to diagnosis, and three about optional analyses of associations between time to diagnosis and participant characteristics and health outcomes. Of 24 responding authors of systematic reviews, more than 21 (≥88 %) rated the items as relevant, and more than 17 (≥70 %) as readable; 19 of 22 (86 %) authors stated that they would potentially use the reporting guideline in the future. CONCLUSIONS: We propose a reporting guideline (REST) that could help authors, reviewers, and editors of time to diagnosis study reports to improve the completeness and the accuracy of their reporting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0690-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-27 /pmc/articles/PMC5039933/ /pubmed/27677259 http://dx.doi.org/10.1186/s12916-016-0690-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Guideline Launay, Elise Cohen, Jérémie F. Bossuyt, Patrick M. Buekens, Pierre Deeks, Jonathan Dye, Timothy Feltbower, Richard Ferrari, Andrea Kramer, Michael Leeflang, Mariska Moher, David Moons, Karel G. von Elm, Erik Ravaud, Philippe Chalumeau, Martin Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST) |
title | Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST) |
title_full | Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST) |
title_fullStr | Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST) |
title_full_unstemmed | Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST) |
title_short | Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST) |
title_sort | reporting studies on time to diagnosis: proposal of a guideline by an international panel (rest) |
topic | Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039933/ https://www.ncbi.nlm.nih.gov/pubmed/27677259 http://dx.doi.org/10.1186/s12916-016-0690-7 |
work_keys_str_mv | AT launayelise reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT cohenjeremief reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT bossuytpatrickm reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT buekenspierre reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT deeksjonathan reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT dyetimothy reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT feltbowerrichard reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT ferrariandrea reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT kramermichael reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT leeflangmariska reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT moherdavid reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT moonskarelg reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT vonelmerik reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT ravaudphilippe reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest AT chalumeaumartin reportingstudiesontimetodiagnosisproposalofaguidelinebyaninternationalpanelrest |